Open access
Open access
Powered by Google Translator Translator

U.S. regulators pause Johnson & Johnson vaccine rollout over rare (1 in a million) cases of blood clots

14 Apr, 2021 | 02:16h | UTC

Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine – U.S. Food & Drug Administration

Commentaries: Covid-19: US suspends Johnson and Johnson vaccine rollout over blood clots – BMJ AND CDC and FDA recommend US pause use of Johnson & Johnson’s Covid-19 vaccine over blood clot concerns – CNN AND US halts J&J COVID vaccine after reports of blood clots – CIDRAP AND U.S. urges pause on use of Johnson & Johnson Covid-19 vaccine after rare blood clotting cases – CIDRAP

 


Stay Updated in Your Specialty

No spam, just news.